• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

How physicians can deal with the ‘tripledemic’ of COVID-19, RSV and influenza


The 2022 respiratory season is shaping up to be uniquely challenging. How can you prepare?

Medical Economics sat down with Kalvin Yu, MD, FIDSA is Vice President Medical & Scientific Affairs, U.S. Region at BD, to discuss the "tripledemic" impacting the 2022 respiratory season, as the spread of influenza, COVID-19 and RSV create a season with unique challenges.

According to CDC records there have been at least 8.7 million illnesses, 78 000 hospitalizations, and 4500 fatalities caused by influenza since October, as of early December. Thanksgiving week also brought 2 new pediatric deaths, bringing fatalities among children thus far to 14.

COVID-19 hospitalizations have also begun to tick up. Respiratory syncytial virus (RSV), like influenza, appeared early this year and caused a surge of pediatric hospitalizations that overwhelmed capacity at children’s hospitals across the country.

Kalvin Yu, MD, FIDSA is Vice President Medical & Scientific Affairs, U.S. Region at BD. Kalvin has over 20 years of clinical inpatient and outpatient experience, research and hospital quality administration. Significant CMS/TJC preparation, pandemic planning, infection control and patient safety program execution in matrixed multi-hospital organizations. He is a former professor of global public health at NYU and graduate of the UCLA School of Medicine.

Related Videos